Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1151P is annotated as a pseudogene corresponding to the U6 small nuclear RNA gene family[2]. The canonical U6 small nuclear RNA (snRNA) is an essential component of the spliceosome, required for pre-mRNA splicing in eukaryotes[1][3]. However, pseudogenes like RNU6-1151P are generally non-functional copies or fragments of functional RNA genes and are not transcribed into functional RNAs or proteins[2][4]. There is currently no evidence that RNU6-1151P has a biological function, role in disease, or is a druggable target. Unlike protein-coding genes or functional ncRNAs, pseudogenes like RNU6-1151P typically do not serve as therapeutic molecular targets. Summary of Key Points: - RNU6-1151P is a non-coding RNA pseudogene with no known function as a protein, enzyme, receptor or drug target[2][4]. - No evidence supports its role in biological processes or diseases. - It is not a therapeutic target. - The entry may be misleading if interpreted as a functional RNA or druggable molecule. If you need a profile for the functional U6 snRNA itself, information will differ significantly, as that is a core spliceosomal RNA involved in mRNA processing[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1151, pseudogene (RNU6-1151P).